BRIACELL THERAPEUTICS CORP. Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable
BRIACELL THERAPEUTICS CORP. (BCTX) had Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable of 22.91 thousand shares as of 2026-04-30, per its 10-Q filed 2026-06-09.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Option, Exercise Price Range, Beginning of Period
us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions · last filed 2026-06-09
- 2026-04-30: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 22.91K shares.
- 2026-01-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 22.68K shares.
- 2025-10-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 17.96K shares.
- 2025-07-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 13.25K shares.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable |
|---|---|
| 2026-04-30 | 22.91K shares 10-Q · filed 2026-06-09 |
| 2026-01-31 | 22.68K shares 10-Q · filed 2026-03-10 |
| 2025-10-31 | 17.96K shares 10-Q · filed 2025-12-11 |
| 2025-07-31 | 13.25K shares 10-K · filed 2025-10-16 |
| 2025-04-30 | 132.76K shares 10-Q · filed 2025-06-16 |
| 2025-01-31 | 141.10K shares 10-Q · filed 2025-03-12 |
| 2024-10-31 | 2.02M shares 10-Q · filed 2024-12-16 |
| 2024-07-31 | 1.96M shares 10-K · filed 2024-10-29 |
| 2024-04-30 | 1.88M shares 10-Q · filed 2024-06-14 |
| 2024-01-31 | 1.80M shares 10-Q · filed 2024-03-18 |
| 2023-10-31 | 1.69M shares 10-Q · filed 2023-12-14 |
| 2023-07-31 | 1.59M shares 10-K · filed 2023-10-25 |
| 2023-04-30 | 1.48M shares 10-Q · filed 2023-06-14 |
| 2023-01-31 | 1.42M shares 10-Q · filed 2023-03-16 |
| 2022-10-31 | 1.37M shares 10-Q · filed 2022-12-14 |
| 2022-07-31 | 1.20M shares 10-K · filed 2022-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |